Page last updated: 2024-10-23

azathioprine and Aldrich Syndrome

azathioprine has been researched along with Aldrich Syndrome in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meisels, IS1
Strom, TB1
Roy-Chaudhury, P1
Abrams, J1
Shapiro, ME1
Doll, R1
Kinlen, L1

Other Studies

2 other studies available for azathioprine and Aldrich Syndrome

ArticleYear
Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome.
    Transplantation, 1995, Apr-27, Volume: 59, Issue:8

    Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Kidne

1995
Immunosurveillance and cancer: epidemiological evidence.
    British medical journal, 1970, Nov-14, Volume: 4, Issue:5732

    Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Chediak-Higashi Syndrome; Child; Child, Preschoo

1970